|
|
ESTECH announces FDA Marketing Clearance for New Surgical Device for Cardiac AblationCardiac Ablation is used by surgeons to create lesions that prevent recurrence of Atrial FibrillationDanville, CA, July 28, 2004- Endoscopic Technologies, Inc. (ESTECH), a medical device company focused on the development and sale of products for use in cardiovascular surgery procedures, announced that they have received FDA 510K Marketing Clearance for a new device for cardiac ablation. This device is used in a procedure performed by cardiac surgeons to create scars that block the electrical impulses that cause Atrial Fibrillation (AF).The new "Cobra® Adhere™ device combines proven RF ablation technology with a suction application method that allows the surgeon to create lesions on the outside of the heart while it is still beating. The device is designed for use in traditional surgery procedures and can also be used for minimally invasive applications. Tamer Ibrahim Vice President of Research and Development said "This product will offer a significant advancement in methods to treat an underserved patient population." He went on to say" over than 2 million people in the US are currently living with AF and exposed to very a significant risk of stroke." (AF is the leading cause of stroke). ESTECH expects to have limited release of the Cobra® Adhere™ device this fall and release an additional version the "Cobra® Adhere XL™" in 2005. About ESTECH ESTECH is a headquartered in San Ramon, CA and offers tools for least Invasive techniques and traditional approaches to the procedures that cardiac surgeons do every day - Coronary Artery Bypass, Valve Surgery, Atrial Ablation and Surgical Treatment of Congestive Heart Failure. Note to Editors: ESTECH, Inc., Least Invasive Cardiac Surgery and "Cobra" are trademarks owned by or licensed to Endoscopic Technologies, Inc.
Back to News |
|||||||||||||